Clinical Evaluation of Metal Panel Allergens: Dose Response Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Akiko Yagami, MD, PhD
Fujita Health University School of Medicine, Japan
Principal Investigator - Andreas Bircher, MD
University Hospital, Basel, Switzerland
Principal Investigator - Karin Pacheco, MD
National Jewish Health School of Medicine, Colorado USA
Principal Investigator - Maki Hosoki, DDS, PhD
Tokushima University Graduate School, Japan
Principal Investigator - Paolo Pigatto, MD
University of Milano, Italy
Principal Investigator - Patricia L Norris, MD
Oregon Health & Science University, Portland USA
Principal Investigator - Peter Thomas, MD
Ludwig-Maximilians-Universität München, Germany
Principal Investigator - Risa Tamagawa-Mineoka, MD
Kyoto Prefectural University of Medicine, Japan
Principal Investigator - Thomas Rustemeyer, MD, PhD
VU University Medical Center, Netherlands
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ludwig-Maximilians-Universitat Munchen
Munich, Germany
- University of Milano
Milan, Italy
- Fujita Health University School of Medicine
Aichi, Japan
- Kyoto Prefectural University of Medicine
Kyoto, Japan
- Tokushima University Graduate School
Tokushima, Japan
- Vu University Medical Center
Amsterdam, Netherlands
- University Hospital Basel Allergology Unit
Basel, Switzerland
- National Jewish Health, University of Colorado Denver
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Dec 2016
- Primary completion
- 15 Jul 2019
- Completion
- 15 Jul 2019
- Last update posted
- 25 Aug 2020
- Registered enrollment
- 122
- Registry id
- NCT02615249
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.